Innovation is key to achieving true differentiation and sustaining a competitive advantage. This has never been truer than in today’s rapidly evolving economy, requiring companies to develop new products and streamline processes all while delivering increased value to customers.
R&D investment has never been higher. According to PwC’s 2017 13th annual study on Global Innovation, total R&D spending by the Global Innovation 1000 (the world’s 1,000 largest corporate R&D spenders) exceeded $700B for the first time. Consistently in the top three, healthcare is poised to be the highest R&D spending industry by 2018.
While innovation is a top priority for healthcare companies in general, and in vitro diagnostic (IVD) manufacturers in particular, it continues to be a frustration for organizations in its execution.